Insiders · Profile

Jamil Khurram

Chief Medical Officer at GALECTIN THERAPEUTICS. Filing since 23 Dec 2024. CIK 0002032345

Company

Date

Role

Action

Shares

Amount

Of holding

GALT GALECTIN THERAPEUTICS INC

14 Jul 2026

Chief Medical Officer

Sold on a plan

16,250

$83.28K

100%

GALT GALECTIN THERAPEUTICS INC

29 Jun 2026

Chief Medical Officer

Sold on a plan

47,467

$239.23K

100%

GALT GALECTIN THERAPEUTICS INC

26 Jun 2026

Chief Medical Officer

Sold on a plan

4,570

$22.85K

100%

GALT GALECTIN THERAPEUTICS INC

23 Jun 2026

Chief Medical Officer

Sold on a plan

7,557

$23.73K

100%

GALT GALECTIN THERAPEUTICS INC

26 May 2026

Chief Medical Officer

Sold on a plan

568

$1.76K

100%

GALT GALECTIN THERAPEUTICS INC

6 Jan 2026

Chief Medical Officer

Sold on a plan

21,446

$78.20K

100%

GALT GALECTIN THERAPEUTICS INC

5 Jan 2026

Chief Medical Officer

Sold on a plan

25,499

$99.41K

54.3%

GALT GALECTIN THERAPEUTICS INC

2 Jan 2026

Chief Medical Officer

Sold on a plan

13,055

$54.79K

21.8%

GALT GALECTIN THERAPEUTICS INC

31 Dec 2025

Chief Medical Officer

Sold on a plan

8,125

$33.09K

100%

GALT GALECTIN THERAPEUTICS INC

17 Dec 2025

Chief Medical Officer

Sold on a plan

19,442

$136.87K

100%

GALT GALECTIN THERAPEUTICS INC

13 Nov 2025

Chief Medical Officer

Sold on a plan

121,117

$662.51K

96.4%

GALT GALECTIN THERAPEUTICS INC

23 Dec 2024

Chief Medical Officer

Sold on a plan

13,654

$12.04K

34.1%

12 decisions on file.